Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Us and it
This article by Gerard Quinn, Vice President of IT Innovation and Informatics, which appeared in PharmaTimes Magazine, delves into how AI is transforming clinical trials by improving efficiency, accelerating timelines, and enhancing decisions across the clinical development process.
-
Streamlining bioprocesses with automation
In this article from BioPharm International, Ronan Fox, Senior Vice President, IT R&D, provides commentary on the evolving role of automation in biopharmaceutical development.
-
DCT Tracker: Charting the next chapter for decentralisation
More than four years after decentralisation became a necessity in the clinical trials space, the sector is still finding its way around decentralised clinical trials (DCTs). And like any other paradigm shift, the journey has taken several turns.
-
Human-enabled AI driving enhancements in clinical trial site selection
In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.
-
Pivoting toward sustainable supply chains in clinical research
In this article from Applied Clinical Trials, Kelly Corkey, Director, Clinical Supplies Management, IRT and Leonard Wee, VP, Global Supply Chain, Laboratories outline how by adopting a holistic approach that optimises each component of the process, the clinical research industry can collectively drive progress and pivot toward a greener future while continuing to support patient-centred clinical research.
-
Current state of drug development, clinical trials and precision measures
This article in the Journal of mHealth, provides an overview of a recent npj Nature publication, that proposes enough alignment exists between independent traditional COA and DHT libraries to build a single framework for researchers to identify and compare actively-collected versus passively-monitored tools for the same or similar measure. Article is by Caprice Sassano, Research Lead – Applied Sciences at HumanFirst, an ICON company, with collaboration from Dr. Roya Sherafat, Scientific Director, MAPI Research Trust and Marcelo Alves Favaro, Associate Outcomes Researcher, MAPI Research Trust.
-
Advancing clinical research through effective data delivery
In this article from The Scientist, Rose Kidd, President of Global Operations Delivery, explains how clinical researchers ensure impeccable data collection and delivery in increasingly complex trials.
-
Data integration frameworks key for embracing big data’s potential
Rick Rosenthal and Paula Fullman of Symphony Health, an ICON plc company, explain how to navigate the complexities and challenges of the evolving digital landscape of healthcare data in this article from PharmaTimes.
-
IMI Mobilise-D: The next generation of mobility research
In this article from International Pharmaceutical Industry, Gerard Quinn, VP, IT Innovation and Informatics, provides an overview on the Innovative Medicines Initiative (IMI) funded Mobilise-D project, which aims to develop a comprehensive system to analyse people’s gait using digital technologies, including sponsors worn on the body.
-
AI has the power to revolutionise drug discovery and design
In this article from the Irish Times, Gerard Quinn, VP of IT Innovation and Informatics provides insight on how artificial intelligence can support the drug development process in order to deliver new treatments to more people, faster.
